2023³â Á¦20Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ÀÎõ°æ±âÁöȸ Çмú´ëȸ : 2023-12-02
±³À°ÀÏÀÚ : 2023-12-02
±³À°Àå¼Ò : ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ : 2023³â Á¦20Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ÀÎõ°æ±âÁöȸ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ÀÎõ°æ±âÁöȸ
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190
À̸ÞÀÏ : urology@urology.or.kr
±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 12:30~13:00 µî·Ï ( )
±âŸ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 13:00~13:10 Àλ縻 ¾ÈÇö¼ö(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 13:10~13:25 Impact of incontinence surgery in female sexual function À̼ҿ¬(ÇѾçÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 13:25~13:40 Update on medical treatment of BPH À¯¿µµ¿(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 13:40~13:55 Current state of AI toward automated surgery ±èÁø¿í(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 13:55~14:10 Update on surgical treatment of BPH ¹è»ó¶ô(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 14:10~14:25 Individualizing care of low-risk prostate cancer in the era of active surveillance Źü½Ä(°í·ÁÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 14:25~14:40 Lymph node dissection at radical prostatectomy ¹ÚºÀÈñ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 14:40~14:55 How systemic treatment should be used for men with high-risk localized prostate cancer? ³ªÁØä(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 14:55~15:10 PARP inhibitors for mCRPC: for all or for biomarker-dependent? ÃÖÁß¿ø(Áß¾ÓÀÇ´ë)
ÈÞ½Ä 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 15:10~15:30 ´Üü»çÁø ¹× Coffee break ( )
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 15:30~15:45 Second line therapy for NMIBC recurrence after BCG therapy ±ÇÈÖ¾È(ÇѾçÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 15:45~16:00 Radical cystectomy in the elderly and co- morbidity Ãß¼³È£(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 16:00~16:15 Tips and tricks for complex renal tumor surgery ±èÁ¤±Ç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 16:15~16:30 Who is the best candidate for adjuvant therapy in RCC? ±èÇüÈ£(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 16:30~16:45 What¡¯s New in Disposable Flexible Ureteroscope? ±è¿õºó(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 16:45~17:00 Medical Expulsive Therapy for Urolithiasis Á¤µÎ¿ë(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 17:00~17:15 Guidelines of UTI Diagnosis in Korea ÃÖÁøºÀ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 17:15~17:30 STI Prevalence, Incidence, and Trends in Korea ÃÖâÀÏ(ÇѸ²ÀÇ´ë)
±âŸ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 17:30~18:00 ÀÎõ-°æ±âÁöȸ ÃÑȸ Á¤¼ºÁø(¼¿ïÀÇ´ë)
±âŸ 12¿ù 02ÀÏ ºÐ´ç¼¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°´ç 18:00~18:10 Closing ( )